根据最新的SEC文件显示,Apogee Therapeutics, Inc. (NASDAQ: APGE )首席执行官Michael Henderson已出售15,000股公司普通股。这家市值23.7亿美元的生物科技公司目前获得分析师一致"强烈买入"评级,目标价区间为80美元至110美元。此次股票以平均价格40.58美元售出,总计60.87万美元。该交易是根据2023年9月25日采用的Rule ...
Okta, Inc. (NASDAQ: OKTA )董事Jacques Frederic ...
BEIJING, Feb. 5 (Xinhua) — Xi Jinping, chairman of the Central Military Commission, has signed an order to promulgate a set of revised regulations on scientific research related to military equipment.
BEIJING, Feb. 4 (Xinhua) -- China has filed a complaint with the World Trade Organization (WTO)'s dispute settlement mechanism against the U.S. decision to impose an additional 10-percent tariff on ...